What is the official ID of this bill?

The official print number for this legislation is HR 1227.

When did the legislative process begin?

The process officially started on 2025-02-12.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: https://www.congress.gov/119/bills/hr1227/BILLS-119hr1227ih.htm

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-1].

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

What is the latest detailed status?

The latest detailed status is: Introduced in House

Analysis and Potential Impact of HR 1227

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

Improved Access to Non-Opioid Pain Management Drugs in Medicare

Q: What are the main provisions?

Key points include: No deductible for qualifying non-opioid pain management drugs under Medicare Part D starting January 1, 2026. Non-opioid pain drugs will be placed on the lowest cost-sharing tier, reducing patient expenses. Prohibition of 'step therapy' (requiring opioid use first) and prior authorization for non-opioid pain medications.

New rules will make it easier for seniors and Medicare beneficiaries to access non-opioid pain management drugs. This means lower out-of-pocket costs and no prior approval needed for these medications, aiming to combat opioid addiction.

Key points

No deductible for qualifying non-opioid pain management drugs under Medicare Part D starting January 1, 2026.

Non-opioid pain drugs will be placed on the lowest cost-sharing tier, reducing patient expenses.

Prohibition of 'step therapy' (requiring opioid use first) and prior authorization for non-opioid pain medications.

article Official text account_balance Process page notifications_active Track this Bill

gavel

Status:

Introduced

Record your position for audit.

Why does your vote on bills matter?

It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.

Additional Information

Alternatives to PAIN Act

Print number: HR 1227

Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-1]

Process start date: 2025-02-12

System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.

Summarized by: gemini-2.5-flash

Source data: api.congress.gov

AI work logs for this document launch